HDK® N20 PHARMA
Synthetic, hydrophilic amorphous silica, produced via flame hydrolysis.
All the information provided is in accordance with the present state of our knowledge. Nonetheless, we disclaim any warranty or liability whatsoever and reserve the right, at any time, to effect technical alterations. The information provided, as well as the product's fitness for an intended application, should be checked by the buyer in preliminary trials. Contractual terms and conditions always take precedence. This disclaimer of warranty and liability also applies particularly in foreign countries with respect to third parties' rights.
HDK® N20 PHARMA is intended for use in pharmaceuticals. It improves the flow of powders and is used as glidant for tableting. Furthermore, HDK® N20 PHARMA is a thickener for liquid pharmaceutical products. HDK® N20 PHARMA is tested according to the pharmacopeias EP and USP/NF. (Produced according to ISO 9001, ISO 14001, HACCP and IPEC).
A good mixing and dispersion of HDK® N20 PHARMA is a must to assure optimum performance.
More detailed information about the application and processing of HDK® N20 PHARMA is available in our HDK-brochures and on the WACKER web site
HDK® N20 PHARMA is offered in following packaging:
- pallet with paper bags: 10 kg bags